Skip to content

Evaluation of autonomic nervous system before and after inhalation of the fragrant component added to ethanol water.

Evaluation of autonomic nervous system before and after inhalation of the fragrant component added to ethanol water. - Evaluation of autonomic nervous system before and after inhalation of the fragrant component added to ethanol water.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000034314
Enrollment
22
Registered
2018-09-28
Start date
2018-09-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Smell the scent of 2 kinds of component (A,B) in order A and B. Smell the scent of 2 kinds of component (A,B) in order B and A.

Sponsors

CPCC Company Limited
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (1) Females aged 25 to 45 years old. (2)Subjects who like sake, especially ginjo-sake and have experience of drinking sake. (3) Subjects who show understanding of the clinical study procedures and agreement with participating the study by written informed consent.

Exclusion criteria

Exclusion criteria: (1)Subjects who dislike the scent of sake. (2)Subjects who can't drink alcohol or who can drink alcohol little. (3) Subjects who have smoking habit. (4) Subjects who are cold-sensitive constitution. (including subjects like that who feel cold on their hands and foots even in summer) (5) During the past month, subjects who have been received medication for the treatment of diseases. (6) During the past month, subjects who have been received treatment of pollen allergy. (7) Subjects who have stuffy nose from allergic rhinitis or who can't distinguish scent. (8) Subjects who have previous and/or current medical history of serious disease in liver, kidney, heart, lung and/or blood. (9) Subjects with high blood pressure symptoms such as systolic blood pressure of 160 mmHg and more or diastolic blood pressure of 100 mmHg and more. (10) Pregnant or expected pregnant, or lactating women. (11) Subjects who have symptom of dermatologic disease such as atopic dermatitis. (12) Subjects who have undergone surgery on investigation objective portion within the past 6 months. (13) Subjects who are participating the other clinical tests of medicines or foods. Subjects who participated other clinical tests of medicines or foods within a month prior to the current study. (14) Subjects who themselves and/or their family are working for a company that develops, manufactures or sells alcoholic beverages, health / functional foods and cosmetics. (15) Others who have been determined ineligible by investigator.

Design outcomes

Primary

MeasureTime frame
Evaluation of autonomic nervous system

Secondary

MeasureTime frame
Multifaceted emotional state scale shortened version VAS questionnaire about change of feeling VAS questionnaire about fragrance VAS questionnaire about sake

Countries

Japan

Contacts

Public ContactMasanori Numa

CPCC Company Limited Planning & Sales Department

cpcc-contact@cpcc.co.jp03-5297-3112

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026